Effects of topical erythromycin and clindamycin on acne

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the combined effects of topical erythromycin and clindamycin on patients with acne vulgaris. It will utilize both conventional assessment methods, such as lesion counts and global assessment scales, as well as advanced techniques like multi-modal photo analysis and laser speckle contrast imaging. The goal is to gain a deeper understanding of how these treatments affect acne through extensive response profiling and mechanistic insights from in vitro and in vivo studies. Participants will undergo skin biopsies to analyze local skin surface and microbiota.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Healthy male and female subjects, 18 to 45 years of age. The health status is verified by absence of evidence of any clinical significant active or uncontrolled chronic disease other than AV following a detailed medical history, a complete physical examination including vital signs, 12-lead ECG, hematology, blood chemistry, virology and urinalysis;
2. Mild to moderate inflammatory acne vulgaris on the face, ≥5 inflammatory lesions (papules and/or pustules), present at screening and baseline visit
3. A maximum of 5 nodules present at screening and baseline visit
4. Inflammatory acne present for at least 6 months
5. Fitzpatrick skin type I-II (Caucasian)
6. Able and willing to give written informed consent and to comply with the study restrictions.
7. Willing to comply with 2x2mm facial skin punch biopsies

Exclusion Criteria:

1. Severe acne where systemic treatment is needed
2. Use of any topical (anti-acne) medication (prescription or OTC) within 2 weeks prior to baseline
3. Use of any oral/systemic treatment for acne, including oral antibiotics, excluding OAC, within 4 weeks prior to baseline
4. Use of systemic isotretinoin within 6 months prior to baseline
5. History of pathological scar formation (keloid, hypertrophic scar)
6. Known hypersensitivity to erythromycin or clindamycin, drugs of the same class, or any of their excipients.
7. Known contact dermatitis reaction to any product
8. Tanning due to sunbathing, excessive sun exposure or a tanning booth within 3 weeks of enrollment.
9. Participation in an investigational drug or device study within 3 months prior to screening or more than 4 times a year.
10. Loss or donation of blood over 500 mL within three months (males) or four months (females) prior to screening
11. Pregnant, a positive pregnancy test, intending to become pregnant, or breastfeeding

Where it's running

• Centre for Human Drug Research
  Leiden, Netherlands Recruiting

Study contacts

• Principal investigator: Robert Rissmann, PharmD, PhD — Chdr
• Study coordinator: Robert Rissmann, PharmD, PhD
• Email: clintrials@chdr.nl
• Phone: +31 71 5246 400

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Nadifloxacin Plus Tretinoin vs Clindamycin Plus Tretinoin for Mild-to-Moderate Acne

  This study tests whether nadifloxacin with tretinoin cream works better than clindamycin with tretinoin cream for adults with mild-to-moderate acne.

  Recruiting Phase 4 Nishtar Medical University · Multan, Punjab Province · NCT07915648

• Topical clascoterone vs. adapalene for mild-to-moderate acne in teens and young adults

  This trial tests whether clascoterone 1% cream works as well as adapalene 0.1% cream for treating mild-to-moderate acne in people aged 12–55.

  Recruiting Pak Emirates Military Hospital · Rawalpindi, Punjab Province · NCT07883538

• Denifanstat vs placebo for moderate to severe acne in teens and adults

  This study tests whether denifanstat works safely to improve acne in people 12 and older, compared with a matching placebo.

  Recruiting at 28 sites Phase 3 Sagimet Biosciences Inc. · Bryant, Arkansas and 27 other locations · NCT07863193

• Facial skin microbiome changes during isotretinoin in moderate-to-severe acne

  This study tests how the facial skin microbiome changes in people with moderate-to-severe acne who are treated with isotretinoin, and compares them with healthy individuals.

  Recruiting Can Tho University of Medicine and Pharmacy · Can Tho · NCT07834138

• Prevalence of PMOS in women with acne at Sohag University Hospital

  This study tests how common polyendocrine metabolic ovarian syndrome (PMOS) is among women with acne who are seen at Sohag University Hospital.

  Recruiting Sohag University · Sohag · NCT07822360

• Hormonal profiles and isotretinoin response in adult women with acne

  This study tests whether baseline hormones (DHEAS, FSH, and LH) help predict how adult women with acne will respond to systemic isotretinoin.

  Recruiting Biruni University · Küçükçekmece, Istanbul · NCT07818525

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.